A better return on your Behavioral Health dollars.
We have been selected by multiple states to deploy eTMS to their Veterans, First Responders, and Law Enforcement Officers. We measure every patient on gold-standard scales and report the outcomes back to you. You don’t fund a promise, you fund proof.
Behavioral health is expensive, and hard to hold accountable.
Overdoses, repeated detox, emergency care, incarceration, and lost productivity make untreated mental illness and addiction one of the costliest problems states face. Dollars go out the door, but agencies rarely get to see, patient by patient, what changed.
JLC was built to close that gap. We are a data-and-outcomes company that deploys proven neurotechnology and measures relentlessly, so every dollar is tied to a result you can see.
What we deliver to a state partner
Turn-key deployment
FDA-cleared, EEG-guided eTMS deployed into your communities and treatment centers.
Validated measurement
Validated outcome measurement on every patient, before, during, and after care.
De-identified dashboards
Dashboards that show enrollment, scales completed, and results in real time.
A tax-ROI narrative
A story your leadership can take to appropriators and the public.
Accountability built in
Fund against measured reductions, not activity.
Measured and reported every step of the way.
Multiple states have selected JLC to deploy eTMS to their Veterans, First Responders, and Law Enforcement Officers.
patients treated
avg. symptom reduction
states selected us
Fund lasting recovery, not repeat cycles.
Widely cited research finds every dollar invested in addiction treatment returns roughly fourfold or more in reduced crime, healthcare, and lost-productivity costs. eTMS targets the cravings and brain dysfunction that drive relapses, so public funds buy durable outcomes. And because we measure every patient, you can see the return.
How partnership works: from appropriation to accountable outcomes.
1 · Deploy
Stand up eTMS and a trained team inside your existing treatment infrastructure, quickly and turn-key.
2 · Measure
Every enrolled patient on validated scales, EEG, and digital biomarkers.
3 · Report
De-identified dashboards give live visibility into enrollment and results.
4 · Prove & scale
Outcomes justify the program to appropriators and support expansion.
Let's put a measurable program in front of your appropriators.
Request a 30-minute briefing with our clinical team and a walkthrough of the outcomes dashboard.
eTMS uses FDA-cleared transcranial magnetic stimulation technology. eTMS/MeRT is not FDA-cleared for autism spectrum disorder or substance use disorder; those uses are personalized, innovative, and not a cure. Individual results vary. Outcome figures represent average change from baseline across measured patients and are not a guarantee of results. Content is for informational purposes and is not medical advice.